AU2021268757A1 - Peptide tags and binding partners - Google Patents
Peptide tags and binding partners Download PDFInfo
- Publication number
- AU2021268757A1 AU2021268757A1 AU2021268757A AU2021268757A AU2021268757A1 AU 2021268757 A1 AU2021268757 A1 AU 2021268757A1 AU 2021268757 A AU2021268757 A AU 2021268757A AU 2021268757 A AU2021268757 A AU 2021268757A AU 2021268757 A1 AU2021268757 A1 AU 2021268757A1
- Authority
- AU
- Australia
- Prior art keywords
- seq
- binding partner
- peptide tag
- homology
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Mycology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20173377.1 | 2020-05-07 | ||
| EP20173377 | 2020-05-07 | ||
| PCT/EP2021/062113 WO2021224451A1 (en) | 2020-05-07 | 2021-05-07 | Peptide tags and binding partners |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2021268757A1 true AU2021268757A1 (en) | 2022-12-08 |
Family
ID=70613720
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2021268757A Pending AU2021268757A1 (en) | 2020-05-07 | 2021-05-07 | Peptide tags and binding partners |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230321260A1 (https=) |
| EP (1) | EP4146675A1 (https=) |
| JP (2) | JP7843245B2 (https=) |
| KR (1) | KR20230006473A (https=) |
| CN (1) | CN115698045A (https=) |
| AU (1) | AU2021268757A1 (https=) |
| BR (1) | BR112022019632A2 (https=) |
| CA (1) | CA3177709A1 (https=) |
| IL (1) | IL297111A (https=) |
| MX (1) | MX2022013938A (https=) |
| WO (1) | WO2021224451A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016112921A1 (en) | 2015-01-15 | 2016-07-21 | University Of Copenhagen | Virus-like particle with efficient epitope display |
| WO2022229817A1 (en) * | 2021-04-28 | 2022-11-03 | Bavarian Nordic A/S | Vaccines comprising virus-like particles displaying sars-cov-2 antigens and methods of use |
| US20240240203A1 (en) | 2021-05-04 | 2024-07-18 | SpyBiotech Limited | Adenoviral vectors and vaccines thereof |
| EP4593874A2 (en) | 2022-09-30 | 2025-08-06 | Bavarian Nordic A/S | Virus-like particles displaying sars-cov-2 antigens as booster vaccines and uses thereof |
| CN116165377A (zh) * | 2023-04-21 | 2023-05-26 | 常州伯仪生物科技有限公司 | 一种通过竞争elisa法进行标签蛋白定量的方法 |
| WO2025097030A1 (en) * | 2023-11-02 | 2025-05-08 | Oregon State University | Virus-like particles displaying neisseria gonorrhoeae antigens and use thereof for immunization against gonorrhea |
| GB202317925D0 (en) | 2023-11-23 | 2024-01-10 | Spybiotech Ltd | Vaccines |
| CN117723749B (zh) * | 2024-02-07 | 2024-06-04 | 南昌大学 | 基于分子粘合剂的动态光散射免疫传感检测方法 |
| WO2026039325A2 (en) | 2024-08-12 | 2026-02-19 | Regeneron Pharmaceuticals, Inc. | Modified mtm1 genes and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201002362D0 (en) | 2010-02-11 | 2010-03-31 | Isis Innovation | Peptide tag systems that spontaneously form an irreversible link to protein partners via isopeptide bonds |
| PL3215614T3 (pl) * | 2014-11-03 | 2019-12-31 | Merck Patent Gmbh | Rozpuszczalne białka fuzyjne inteiny i sposoby oczyszczania biocząsteczek |
| WO2016112921A1 (en) | 2015-01-15 | 2016-07-21 | University Of Copenhagen | Virus-like particle with efficient epitope display |
| GB201509782D0 (en) * | 2015-06-05 | 2015-07-22 | Isis Innovation | Methods and products for fusion protein synthesis |
| US11807671B2 (en) * | 2016-11-16 | 2023-11-07 | Auckland Uniservices Limited | Methods for protein ligation and uses thereof |
| CN111073925B (zh) * | 2018-10-19 | 2022-04-26 | 北京大学 | 一种基于无序蛋白偶联酶的高效多肽-多肽偶联系统和方法 |
-
2021
- 2021-05-07 WO PCT/EP2021/062113 patent/WO2021224451A1/en not_active Ceased
- 2021-05-07 US US17/917,214 patent/US20230321260A1/en active Pending
- 2021-05-07 BR BR112022019632A patent/BR112022019632A2/pt unknown
- 2021-05-07 IL IL297111A patent/IL297111A/en unknown
- 2021-05-07 JP JP2022567869A patent/JP7843245B2/ja active Active
- 2021-05-07 CA CA3177709A patent/CA3177709A1/en active Pending
- 2021-05-07 CN CN202180038063.4A patent/CN115698045A/zh active Pending
- 2021-05-07 EP EP21722939.2A patent/EP4146675A1/en active Pending
- 2021-05-07 MX MX2022013938A patent/MX2022013938A/es unknown
- 2021-05-07 AU AU2021268757A patent/AU2021268757A1/en active Pending
- 2021-05-07 KR KR1020227036447A patent/KR20230006473A/ko active Pending
-
2025
- 2025-12-19 JP JP2025267995A patent/JP2026048917A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20230006473A (ko) | 2023-01-10 |
| CA3177709A1 (en) | 2021-11-11 |
| BR112022019632A2 (pt) | 2023-10-03 |
| EP4146675A1 (en) | 2023-03-15 |
| MX2022013938A (es) | 2022-11-30 |
| WO2021224451A9 (en) | 2022-05-27 |
| JP7843245B2 (ja) | 2026-04-09 |
| JP2023525752A (ja) | 2023-06-19 |
| JP2026048917A (ja) | 2026-03-17 |
| US20230321260A1 (en) | 2023-10-12 |
| CN115698045A (zh) | 2023-02-03 |
| WO2021224451A1 (en) | 2021-11-11 |
| IL297111A (en) | 2022-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2021268757A1 (en) | Peptide tags and binding partners | |
| CN113861278B (zh) | 一种产生广谱交叉中和活性的重组新型冠状病毒rbd三聚体蛋白疫苗、其制备方法和应用 | |
| US10197562B2 (en) | Multiplex immuno screening assay | |
| US10247727B2 (en) | Peptide tag system that spontaneously form an irreversible link to protein partners via isopeptide bonds | |
| CN113621031B (zh) | 一种利用自发异肽键进行蛋白共价自组装的肽链接头的组合 | |
| CN116199733A (zh) | 融合蛋白合成的方法和产品 | |
| JP2018141017A (ja) | 可溶性インテイン融合タンパク質、及び生体分子を精製する方法 | |
| JP2018520675A (ja) | ジユビキチン変異タンパク質をベースとした新規結合タンパク質及びその生成方法 | |
| CN113121704B (zh) | 基于纳米颗粒的冠状病毒疫苗 | |
| CN113144187B (zh) | 一种含EB病毒gHgLgp42蛋白的自组装纳米颗粒及其制备方法与应用 | |
| GB2535753A (en) | Particles comprising fusion proteins | |
| CN116444623B (zh) | 一种基于纳米颗粒支架的纳米疫苗及其制备方法与应用 | |
| KR102014901B1 (ko) | 단백질에 대한 나노운반체로서의 순도 및 안정성이 증진된 바이러스 유사 입자의 제조방법 | |
| JP4108000B2 (ja) | 蛋白質の製造方法 | |
| CN112941095A (zh) | 大熊猫轮状病毒ch-1毒株vp7蛋白的重组载体、基因工程菌及其应用 | |
| US12344639B2 (en) | Chimeric gas vesicle and protein expression system therefor | |
| CN120025428B (zh) | 一种靶向NS3a的纳米抗体及其应用 | |
| WO2024071043A1 (ja) | ヘテロ多量体タンパク質の製造方法、タンパク質、核酸、発現ベクター、形質転換体、およびタンパク質の製造方法 | |
| WO2024238632A2 (en) | Asymmetric circular tandem repeat proteins | |
| WO2026037258A1 (zh) | 具有改善的热稳定性的分选酶 | |
| HK40067420B (en) | Recombinant trimeric rbd protein vaccine of novel coronavirus capable of generating broad-spectrum cross-neutralization activity, and preparation method and application thereof | |
| HK40067420A (en) | Recombinant trimeric rbd protein vaccine of novel coronavirus capable of generating broad-spectrum cross-neutralization activity, and preparation method and application thereof | |
| CN120441714A (zh) | 一种广谱性冠状病毒蛋白嵌合型纳米颗粒疫苗及其制备方法与应用 | |
| WO2019198693A1 (ja) | 標的分子と結合するポリペプチド | |
| Manuel-Cabrera et al. | SHORT REPORT Open Access |